Speaker illustration

Professor Thomas Eschenhagen

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

Member of:

Heart Failure Association

Professor Thomas Eschenhagen, MD, studied Medicine at Hannover, trained for 3 years in Cardiology and 5 years in Experimental and Clinical Pharmacology at the University of Hamburg, where he completed a postgraduate study of Molecular Biology in 1992. He served as Director of Clinical Pharmacology at the University of Erlangen (1998-2002) and, since 2002, is Director of the Department of Experimental Pharmacology and Toxicology at the University of Hamburg. Since 2011, he serves as Speaker of the German Centre for Cardiovascular Research, DZHK. He is member of the German Academy of Science Leopoldina (2008) and President of the International Society for Heart Research (2019-2022). He published >280 full papers and >30 reviews or chapters in leading textbooks (>13,500 citations, H index 63). His research aims at a better understanding of cardiomyopathies and translating into the practice the promises of pluripotent stem cells by tissue engineering, a technology he pioneered in 1994.

Cardiac regeneration: heart models and therapeutic interventions

Event: ESC Congress 2022

Topic: Cardiac Biology and Physiology

Session type: Symposium

Thumbnail

Chronic heart failure - Cardiomyopathies

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Moderated ePosters

Thumbnail

Novel therapies for heart failure in the early pipeline

Event: ESC Congress 2021 - The Digital Experience

Topic: Pathophysiology and Mechanisms

Session type: Abstract Sessions

Thumbnail

Cardiac remuscularization: which is the best approach?

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Congress committee e-posters choice in pharmacology and pharmacotherapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Congress Committee e-posters Choice

Thumbnail

Cardiac cell-based therapies: a critical appraisal

Event: ESC CONGRESS 2016

Topic: Stem cells and cell therapy

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk